Bacillus Calmette-Guérin (BCG) shortages and the fragile BCG supply chain have created a bladder cancer treatment vacuum.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

The Food and Drug Administration (FDA) has granted Priority Review to enfortumab vedotin-ejfv (Padcev ™) in combination with pembrolizumab (Keytruda ®) as a neoadjuvant treatment and then continued ...

While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

(HealthDay News) — Cannabis use in 2017 was associated with regular tobacco use in 2021 among U.S. youth and young adults who had never regularly used tobacco, according to a study published online ...

Associations seen for HIV infection, SARS-CoV-2 infection, other viral infections with coronary heart disease, stroke.

Patient and graft survival similar for patients receiving DCD-V from MAiD donation versus conventional DCD-III grafts.

The phase 3 ALBAN trial tested atezolizumab plus BCG in BCG-naïve patients with high-risk, non-muscle-invasive bladder cancer (NMIBC).

The phase 3 POTOMAC trial tested durvalumab added to BCG in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).

Adding EV and pembrolizumab to surgical treatment can improve outcomes in MIBC patients who are ineligible for cisplatin, data suggest.

Investigators presented initial results from a phase 3 trial of adjuvant durvalumab plus tremelimumab for resected primary renal cell carcinoma (RCC).

(HealthDay News) — Primary care physicians (PCPs) spend an average of 61.8 hours per week caring for a patient panel, according to a study published online Oct. 21 in the Annals of Internal Medicine.